<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2172">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 08, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04448743</url>
  </required_header>
  <id_info>
    <org_study_id>7829</org_study_id>
    <nct_id>NCT04448743</nct_id>
  </id_info>
  <brief_title>Role of Microparticles in Covid-19 Infection</brief_title>
  <acronym>MICO</acronym>
  <official_title>Role of Circulating Microparticles in Covid-19 Infection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Among the distinctive features of Covid-19, numerous reports have stressed the importance of&#xD;
      vascular damages associated with coagulopathy onset. Microparticles (MPs) shed by&#xD;
      apoptotic/stimulated cells are reliable markers of vascular damage released upon&#xD;
      pro-inflammatory conditions and behave as active participants in the early steps of clot&#xD;
      formation. In addition, MPs carry ACE1 and ACE2, the cell-entry receptor for SARS-Cov2 in the&#xD;
      vasculature and up-regulate ACE1 expression in neighbouring endothelial cells. This may&#xD;
      contribute to unopposed angiotensin II accumulation which further exacerbate tissue injury&#xD;
      and promote both inflammation and thrombosis. The aim of the study is to evaluate the impact&#xD;
      of circulating MPs on ACE2 expression, the cell-entry receptor for SARS-Cov2 on endothelial&#xD;
      cells.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Circulating MPs will be isolated from Covid-19 patients with lupus anticoagulant, from&#xD;
      coronary artery diseases patients and from healthy volunteers without cardiovascular risk&#xD;
      factors. Quantification of MPs will be realized by prothrombinase assay. Primary endothelial&#xD;
      cells (ECs) from porcine coronary artery or porcine pulmonary artery will be isolated and&#xD;
      cultured. ECs will be exposed to circulating MPs. Phenotypical changes (ACE2 expression,&#xD;
      cytoadhesins, cytokines, tissue factor expression) of ECs will be examined. Susceptibility of&#xD;
      ECs to SARS-COV-2 infection will be determined.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 2020</start_date>
  <completion_date type="Anticipated">November 2021</completion_date>
  <primary_completion_date type="Anticipated">November 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Western blot measurement of ACE2 receptor expression in porcine cells</measure>
    <time_frame>Through study completion, an average of 1 year</time_frame>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">175</enrollment>
  <condition>COVID-19</condition>
  <arm_group>
    <arm_group_label>Covid-19 patients</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>patients with coronary artery disease</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>healthy volunteers</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Blood sample</intervention_name>
    <description>20 Ml blood sample</description>
    <arm_group_label>Covid-19 patients</arm_group_label>
    <arm_group_label>healthy volunteers</arm_group_label>
    <arm_group_label>patients with coronary artery disease</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        -  Covid-19 patients&#xD;
&#xD;
          -  patients with coronary artery disease&#xD;
&#xD;
          -  healthy volunteers&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  COVID-19 patients: age &gt; 18 yr&#xD;
&#xD;
          -  SARS-COV-2 infection within 12 months and positive lupus anticoagulant&#xD;
&#xD;
          -  Patients with cardiovascular risk factors: at least among&#xD;
&#xD;
          -  Hypertension, Dyslipidemia, Diabetes mellitus, obesity, smoker, Healthy volunteers&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Significant comorbidities (active cancer, auto-immune diseasesâ€¦)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>June 22, 2020</study_first_submitted>
  <study_first_submitted_qc>June 25, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 26, 2020</study_first_posted>
  <last_update_submitted>June 25, 2020</last_update_submitted>
  <last_update_submitted_qc>June 25, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 26, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>microparticles</keyword>
  <keyword>microvesicles</keyword>
  <keyword>vessel</keyword>
  <keyword>vasculature</keyword>
  <keyword>endothelium</keyword>
  <keyword>coagulation</keyword>
  <keyword>thrombosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

